InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Muzikant Adam, Directeur Commercial. Officer active across 1 company, notably Flexion Therapeutics Inc. In total, 6 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €20k. History available since 21 June 2021. The latest transaction was filed on 19 November 2021 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
103,666 shares@ US$8.5048.5% of flowCommon StockSEC:0001209191-21-065711
103,666 shares@ US$8.5048.5% of flowCommon StockSEC:0001209191-21-065711:0
1,870 shares@ US$6.450.6% of flowCommon StockSEC:0001209191-21-047503
1,870 shares@ US$6.450.6% of flowCommon StockSEC:0001209191-21-047503:0
2,081 shares@ US$7.780.9% of flowCommon StockSEC:0001209191-21-043524:0
2,081 shares@ US$7.780.9% of flowCommon StockSEC:0001209191-21-043524
6 of 6 declarations
About Muzikant Adam
Adam Muzikant is the Chief Business Officer of Flexion Therapeutics Inc. He is responsible for the company's business strategy, aiming to develop partnerships and increase revenue. His expertise is essential for the growth of Flexion Therapeutics Inc.
